Ignite Creation Date:
2024-05-05 @ 11:23 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00010881
Status:
COMPLETED
Last Update Posted:
2006-08-18
First Post:
2001-02-02
Brief Title:
Oregon Center for Complementary and Alternative Medicine in Neurological Disorders
Sponsor:
National Center for Complementary and Integrative Health NCCIH
Organization:
National Center for Complementary and Integrative Health NCCIH
Study Overview
Official Title:
Oregon Center for Complementary and Alternative Medicine in Neurological Disorders
Status:
COMPLETED
Status Verified Date:
2006-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The mission of the Oregon Center for Complementary and Alternative Medicine in Neurological Disorders ORCCAMIND is to facilitate research and education on the effectiveness and mechanisms of action of complementary and alternative medicine CAM therapies in the treatment of neurological disorders The integration of conventional medicine and CAM communities is critical for the success of ORCCAMIND Thus ORCCAMIND is composed of six institutions Oregon Health Sciences University National College of Naturopathic Medicine Western States Chiropractic College Oregon College of Oriental Medicine the Linus Pauling Institute at Oregon State University and the Portland Veterans Affairs Medical Center
ORCCAMIND will initially focus on the use of CAM antioxidants and stress reduction as treatments for neurodegenerative and demyelinating diseases because many of these diseases have oxidative injury as a causative or contributory factor and several CAM approaches have direct or indirect anti-oxidant effects Through the Career Development Program the Developmental Research Program and the activities of the Education and Information Core we will also foster and promote research into other CAM approaches for neurologic diseases that extend beyond anti-oxidant therapies ORCCAMIND will achieve its goals by carrying out 4 Research Projects and maintaining 4 Core facilities that integrate the research strengths of conventional medicine and CAM practitioners and researchers ORCCAMIND draws its strength from the multi-institutional support and the quality of all its investigators The investigators join ORCCCAMIND with extensive experience with clinical trials patient care externally funded basic and clinical neuroscience research and training programs including federally-funded training grants ORCCAMIND is a bold initiative that integrates basic and clinical research scientists conventional neurologists and CAM practitioners It will promote the exploration of new areas of CAM research and lead research on CAM therapies for neurological disorders
ORCCAMIND will initially focus on the use of CAM antioxidants and stress reduction as treatments for neurodegenerative and demyelinating diseases because many of these diseases have oxidative injury as a causative or contributory factor and several CAM approaches have direct or indirect anti-oxidant effects Through the Career Development Program the Developmental Research Program and the activities of the Education and Information Core we will also foster and promote research into other CAM approaches for neurologic diseases that extend beyond anti-oxidant therapies ORCCAMIND will achieve its goals by carrying out 4 Research Projects and maintaining 4 Core facilities that integrate the research strengths of conventional medicine and CAM practitioners and researchers ORCCAMIND draws its strength from the multi-institutional support and the quality of all its investigators The investigators join ORCCCAMIND with extensive experience with clinical trials patient care externally funded basic and clinical neuroscience research and training programs including federally-funded training grants ORCCAMIND is a bold initiative that integrates basic and clinical research scientists conventional neurologists and CAM practitioners It will promote the exploration of new areas of CAM research and lead research on CAM therapies for neurological disorders
Detailed Description:
See brief summary
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| P50AT000066-01 | NIH | None | httpsreporternihgovquickSearchP50AT000066-01 |